FDA Orange Book · active-ingredient family
Fexofenadine hydrochloride; pseudoephedrine hydrochloride
Fexofenadine hydrochloride; pseudoephedrine hydrochloride is approved as 2 brand and 9 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION · NDA 020786
2
Brand (NDA)
9
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONRLD | CHATTEM SANOFI | NDA 020786 | — | Jan 24, 2011 | |
| ALLEGRA-D 24 HOUR ALLERGY AND CONGESTIONRLD | CHATTEM SANOFI | NDA 021704 | — | Jan 24, 2011 |
Generic (ANDA) products (9)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | L PERRIGO CO | ANDA 216792 | — | Oct 07, 2025 | |
| FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | AUROBINDO PHARMA LTD | ANDA 215232 | — | Apr 17, 2025 | |
| FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | DR REDDYS | ANDA 215434 | — | May 31, 2022 | |
| FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | AUROBINDO PHARMA | ANDA 209116 | — | Oct 30, 2017 | |
| FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | SUN PHARM | ANDA 090818 | — | Jan 29, 2015 | |
| FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | DR REDDYS | ANDA 076667 | — | Nov 18, 2014 | |
| FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | DR REDDYS LABS LTD | ANDA 079043 | — | Jun 22, 2011 | |
| FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | IMPAX PHARMS | ANDA 076298 | — | Nov 12, 2010 | |
| FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | BARR | ANDA 076236 | — | Apr 14, 2005 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Fexofenadine hydrochloride; pseudoephedrine hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

